Cargando…
Can Resveratrol-Inhaled Formulations Be Considered Potential Adjunct Treatments for COVID-19?
The pandemic caused by severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) has led to an extraordinary threat to the global healthcare system. This infection disease, named COVID-19, is characterized by a wide clinical spectrum, ranging from asymptomatic or mild upper respiratory tract...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172170/ https://www.ncbi.nlm.nih.gov/pubmed/34093569 http://dx.doi.org/10.3389/fimmu.2021.670955 |